Health & Biotech
Health & Biotech
Institutions back hotshot Dimerix for COVID-19 study
Health & Biotech
Health Kick: Cynata’s stem cell therapy could be a game changer for COVID-19 patients
Health & Biotech
Greens push for permanent telehealth funding
Health & Biotech
Gi Dynamics investors sign the divorce papers
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Health & Biotech
Dr Boreham’s Crucible: Will EMVision’s links to Nanosonics set it up for similar success?
Health & Biotech
Australia is the next big growth market: Compass Cannabis
Health & Biotech
Investors approve as eSense signs new JV agreement to develop advanced sanitiser products
Health & Biotech
MGC Pharma lands US buyer for the $8.5m sale of its Nutraceuticals business
Health & Biotech
This 60-year old anti-inflammatory medicine is the first COVID-19 treatment to show lifesaving promise
Health & Biotech
Dimerix’s midwinter Christmas present will be FSGS results in July
Health & Biotech
Respiri launches asthma education plan to support pharmacists
Health & Biotech
Cancer fighter Race Oncology is now a 8-bagger in the last 12 months
Health & Biotech
MGC Pharma scoops major Israeli partnership for epilepsy drug
Health & Biotech
No marijuana is ok for pregnant women, not even for morning sickness
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.